Linagliptin

Supplier: ADIPOGEN CORP MS

AG-CR1-3618-M010 AG-CR1-3618-M050
102988-788EA 55.38 USD
102988-788 102988-790
Linagliptin
Linagliptin

Antidiabetic agent. Highly potent and selective competitive inhibitor of dipeptidyl-peptidase 4 (DPP4; DPP IV; CD26), an enzyme that degrades, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Prevents the inactivation of endogenous GLP-1 and GIP. Shown to restore beta cell function and survival in human isolated islets through GLP-1 stabilization. Improves insulin sensitivity. Anti-inflammatory compound.

Formula: C₂₅H₂₈N₈O₂
MDL Number: MFCD14635356
CAS Number: 668270-12-0

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR